1. Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
2. University of Washington School of Medicine, Seattle
3. Center for Tuberculosis Research and Center for Systems Approaches to Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
4. DST/NRF Centre of Excellence for Biomedical TB Research, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and the National Health Laboratory Service, Johannesburg, South Africa
5. Inkosi Albert Luthuli Central Hospital and University of KwaZulu-Natal, Durban, South Africa
6. Department of Microbiology, University of Alabama at Birmingham, Durban, KwaZulu Natal, South Africa
7. Africa Health Research Institute, Durban, KwaZulu Natal, South Africa
8. MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of Research in South Africa, CAPRISA, Durban, South Africa
9. Wellcome Centre for Infectious Diseases Research in Africa, Cape Town, South Africa
10. Institute of Infectious Diseases and Molecular Medicine and Department of Medicine, University of Cape Town, Cape Town, South Africa
11. Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
12. Stop TB Partnership Working Group on New Drugs, New York, New York
13. Global Alliance for TB Drug Development, New York, New York